Coronavirus Vaccine Trial
- All
- News
- Videos
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Wanted: Volunteers To Catch Covid In The Name Of Science
The world's first medical trial authorised to deliberately expose participants to the coronavirus is seeking more volunteers as it steps up efforts to help develop better vaccines.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Trials For Covid Vaccine Pill To Begin In South Africa
South Africa has approved a clinical trial for a Covid vaccine pill, Israeli pharmaceutical company Oramed said on Friday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
Moderna Says Those Vaccinated Earlier Had Higher Rate Of Infections In Study
Moderna Inc. said that a new analysis of the late-stage clinical trial of its Covid-19 vaccine found a higher rate of breakthrough cases in people who got shots early in the study.
-
Single-Dose Sputnik Light Approved For Phase 3 Bridging Trials In India
After the company submitted safety, immunogenicity and efficacy data, the Subject Expert Committee granted permission for conducting the trials in India.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Wanted: Volunteers To Catch Covid In The Name Of Science
The world's first medical trial authorised to deliberately expose participants to the coronavirus is seeking more volunteers as it steps up efforts to help develop better vaccines.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Trials For Covid Vaccine Pill To Begin In South Africa
South Africa has approved a clinical trial for a Covid vaccine pill, Israeli pharmaceutical company Oramed said on Friday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
Moderna Says Those Vaccinated Earlier Had Higher Rate Of Infections In Study
Moderna Inc. said that a new analysis of the late-stage clinical trial of its Covid-19 vaccine found a higher rate of breakthrough cases in people who got shots early in the study.
-
Single-Dose Sputnik Light Approved For Phase 3 Bridging Trials In India
After the company submitted safety, immunogenicity and efficacy data, the Subject Expert Committee granted permission for conducting the trials in India.
